Unknown

Dataset Information

0

Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases.

ABSTRACT:

SUBMITTER: Patnaik MM 

PROVIDER: S-EPMC6202273 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemia.
| S-EPMC11866517 | biostudies-literature
Unknown SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).
| S-EPMC3580040 | biostudies-literature
Unknown Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia.
| S-EPMC3675699 | biostudies-literature
Unknown Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia.
| S-EPMC5737170 | biostudies-literature
Unknown Current Management of Chronic Myeloid Leukemia Myeloid Blast Phase.
| S-EPMC9726842 | biostudies-literature
Unknown Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia.
| S-EPMC11228590 | biostudies-literature
Unknown A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemia.
| S-EPMC12409809 | biostudies-literature
Unknown Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts.
| S-EPMC5940634 | biostudies-literature
Unknown Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia.
| S-EPMC7531999 | biostudies-literature
Unknown Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML.
| S-EPMC9631625 | biostudies-literature